1. Harm Reduction Funding. Regional Trends
Dasha Matyushina-Ocheret
, Vilnius, Lithuania

2. Natural history of the transition
Accept the fact that the GF funding is over
Declare availability of resources for HR
Allocate all/most of available funding for testing and treatment
Let HR NGOs close down
Ask GF/other donors for possible funding

3. Natural history of the transition
Accept the fact that the GF funding is over
Declare availability of resources for HR
Allocate all/most of available funding for testing and treatment
Let HR NGOs close down
Ask GF/other donors for possible funding
Georgia
Russia
Moldova
Belarus
Romania
Kazakhstan
Serbia
Bulgaria

4. Estonia: a case of self-recovery
Accept the fact that the GF funding is over
Declare availability of resources for HR
Allocate all/most of available funding for testing and treatment
Let HR NGOs close down
Ask GF/other donors for possible funding
Estonia

5. Treatment (advocacy) Make transition process transparent
Accept the fact that the GF funding is over
Make transition process transparent
Negotiate gradual transition plan with GF and other donors
Ask GF/other donors for possible funding
Declare availability of resources for HR
Assess HR financial needs
Pilot models of state funding for NGOs
Let HR NGOs close down
Allocate all/most of available funding for testing and treatment
Advocate for separate HR budget lines

6. Regional Report “Road to Success: Toward Sustainable Harm Reduction Funding”
Result of 18 months work of EHRN members and partners in 6 countries
Unified IMG & SMG methodology
Financial analysis: 104 NSP sites and 59 OST sites.
Community-led services assessment: >600 participants of discussion groups & >1,800 questionnaires completed by NSP and OST clients.
Available @

9. NSP & OST unit cost, USD Country NSP OST Belarus 36 612 Georgia 240
1372
Lithuania
332
816
Moldova 49
682
Tajikistan
110
553

10. Domestic funding for harm reduction for 2016-2018 (projections of mid-2015)
Governments provide less than 15% of harm reduction funding in the region, which indicates region’s strong dependency on international donors’ support.
Georgia currently projects no domestic contributions for NSPs through 2018
Moldova and Tajikistan projected domestic contributions that are below 15% and 2% of total needed funding
Kazakhstan has committed substantial domestic funding for NSP, but support to OST is still pending for policy reasons
Lithuanian government’s projected contributions cover only 37% of the demand for NSP

11. Key messages Epidemics among people who
Inject вrugs cannot be reversed
without greater, and sustained,
state funding of harm reduction.
Detailed and responsible transition plans for harm reduction are needed in every EECA country.
Policy reform can maximize the impact and success of harm reduction.

12. What comes next?

13. Domestic finance for needle and syringe programs in (for five countries, commitments in Tbilisi)
$14 142 176,00

14. Needle and Syringe Program financed from domestic sources, % of the full demand

15. Domestic finance for opioid substitution treatment programs
$17 808 361,00

16. Opioid substitution treatment financed from domestic sources, % of the full demand

17. and we have to continue negotiations
All these commitments under threat because of unstable economic situation in all countries of the region
and we have to continue negotiations